TP53BP1 and pancreatic ductal adenocarcinoma: In pancreatic cancer, HNF1A was shown to transcriptionally activate 53BP1 expression, with its expression negatively correlated with oxaliplatin chemoresistance in pancreatic ductal carcinoma (PDAC) tissues and cell lines.